LivaNova PLC (LIVN)
USD 35.56
(-5.14%)
USD 35.56
(-5.14%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 62.53 Million USD | -82.47% |
| 2022 | 356.8 Million USD | 429.38% |
| 2021 | 67.4 Million USD | -84.85% |
| 2020 | 445 Million USD | 37.94% |
| 2019 | 322.6 Million USD | 166.39% |
| 2018 | 121.1 Million USD | 131.11% |
| 2017 | 52.4 Million USD | -36.94% |
| 2016 | 83.1 Million USD | 29.43% |
| 2015 | 64.2 Million USD | 162.15% |
| 2014 | -103.29 Million USD | 14.42% |
| 2013 | -120.7 Million USD | -24.89% |
| 2012 | -96.65 Million USD | -17.49% |
| 2011 | -82.26 Million USD | -87.95% |
| 2010 | -43.76 Million USD | -1026.21% |
| 2009 | -3.88 Million USD | -111.45% |
| 2008 | 33.94 Million USD | -28.84% |
| 2007 | 47.69 Million USD | 35.71% |
| 2006 | 35.14 Million USD | 198.51% |
| 2005 | -35.67 Million USD | 25.97% |
| 2004 | -48.19 Million USD | -37.95% |
| 2003 | -34.93 Million USD | -11.62% |
| 2002 | -31.29 Million USD | 43.04% |
| 2001 | -54.94 Million USD | -282.48% |
| 2000 | -14.36 Million USD | -797.85% |
| 1999 | -1.6 Million USD | 5.88% |
| 1998 | -1.7 Million USD | -112.5% |
| 1997 | -800 Thousand USD | 61.9% |
| 1996 | -2.1 Million USD | 76.14% |
| 1995 | -8.8 Million USD | -100.0% |
| 1994 | -4.4 Million USD | 45.68% |
| 1993 | -8.1 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 61.07 Million USD | -2.33% |
| 2024 Q3 | 279.87 Million USD | 650.83% |
| 2024 Q2 | 44.4 Million USD | -27.29% |
| 2023 FY | 62.53 Million USD | -82.47% |
| 2023 Q1 | 357 Million USD | 0.06% |
| 2023 Q2 | 391.4 Million USD | 9.64% |
| 2023 Q3 | 378.5 Million USD | -3.3% |
| 2023 Q4 | 62.53 Million USD | -83.48% |
| 2022 Q3 | 346.68 Million USD | -10.86% |
| 2022 FY | 356.8 Million USD | 429.38% |
| 2022 Q1 | 373.66 Million USD | 454.4% |
| 2022 Q4 | 356.8 Million USD | 2.92% |
| 2022 Q2 | 388.9 Million USD | 4.08% |
| 2021 Q3 | 106.99 Million USD | -72.43% |
| 2021 Q4 | 67.4 Million USD | -37.01% |
| 2021 Q1 | 459.48 Million USD | 3.26% |
| 2021 FY | 67.4 Million USD | -84.85% |
| 2021 Q2 | 388.09 Million USD | -15.54% |
| 2020 Q4 | 445 Million USD | -6.97% |
| 2020 FY | 445 Million USD | 37.94% |
| 2020 Q3 | 478.31 Million USD | 2.29% |
| 2020 Q2 | 467.61 Million USD | 2.43% |
| 2020 Q1 | 456.5 Million USD | 41.51% |
| 2019 Q2 | 225.89 Million USD | 19.82% |
| 2019 Q1 | 188.52 Million USD | 55.67% |
| 2019 Q4 | 322.6 Million USD | 0.3% |
| 2019 Q3 | 321.64 Million USD | 42.39% |
| 2019 FY | 322.6 Million USD | 166.39% |
| 2018 FY | 121.1 Million USD | 131.11% |
| 2018 Q4 | 121.1 Million USD | 56.87% |
| 2018 Q3 | 77.2 Million USD | -32.04% |
| 2018 Q2 | 113.6 Million USD | -4.05% |
| 2018 Q1 | 118.4 Million USD | 125.95% |
| 2017 Q1 | 60.37 Million USD | -27.35% |
| 2017 FY | 52.4 Million USD | -36.94% |
| 2017 Q4 | 52.4 Million USD | -11.22% |
| 2017 Q3 | 59.02 Million USD | -28.95% |
| 2017 Q2 | 83.07 Million USD | 37.61% |
| 2016 FY | 83.1 Million USD | 29.43% |
| 2016 Q4 | 83.1 Million USD | 0.3% |
| 2016 Q2 | 88.3 Million USD | 4.99% |
| 2016 Q1 | 84.1 Million USD | 30.99% |
| 2016 Q3 | 82.85 Million USD | -6.17% |
| 2015 Q4 | 64.2 Million USD | 133.83% |
| 2015 Q3 | -189.77 Million USD | -16.89% |
| 2015 Q2 | -162.35 Million USD | -30.74% |
| 2015 Q1 | -124.18 Million USD | -6.86% |
| 2015 FY | 64.2 Million USD | 162.15% |
| 2014 FY | -103.29 Million USD | 14.42% |
| 2014 Q4 | -116.21 Million USD | 0.54% |
| 2014 Q3 | -116.84 Million USD | -8.51% |
| 2014 Q2 | -107.67 Million USD | -4.24% |
| 2014 Q1 | -103.29 Million USD | -12.77% |
| 2013 Q4 | -91.6 Million USD | 6.28% |
| 2013 FY | -120.7 Million USD | -24.89% |
| 2013 Q3 | -97.73 Million USD | 8.07% |
| 2013 Q2 | -106.32 Million USD | 11.92% |
| 2013 Q1 | -120.7 Million USD | -3.58% |
| 2012 Q1 | -96.65 Million USD | -23.7% |
| 2012 Q2 | -102.28 Million USD | -5.83% |
| 2012 FY | -96.65 Million USD | -17.49% |
| 2012 Q4 | -116.53 Million USD | 1.66% |
| 2012 Q3 | -118.49 Million USD | -15.85% |
| 2011 Q2 | -74.56 Million USD | 9.36% |
| 2011 Q4 | -78.13 Million USD | -24.45% |
| 2011 FY | -82.26 Million USD | -87.95% |
| 2011 Q1 | -82.26 Million USD | -5.16% |
| 2011 Q3 | -62.78 Million USD | 15.8% |
| 2010 Q2 | -49.6 Million USD | -13.33% |
| 2010 Q1 | -43.76 Million USD | -35.85% |
| 2010 Q4 | -78.22 Million USD | -28.53% |
| 2010 Q3 | -60.86 Million USD | -22.69% |
| 2010 FY | -43.76 Million USD | -1026.21% |
| 2009 Q1 | -3.88 Million USD | -303.67% |
| 2009 Q2 | -9.54 Million USD | -145.55% |
| 2009 Q3 | -21.28 Million USD | -123.03% |
| 2009 Q4 | -32.21 Million USD | -51.38% |
| 2009 FY | -3.88 Million USD | -111.45% |
| 2008 FY | 33.94 Million USD | -28.84% |
| 2008 Q3 | 15.3 Million USD | -35.81% |
| 2008 Q1 | 33.94 Million USD | -3.24% |
| 2008 Q2 | 23.85 Million USD | -29.73% |
| 2008 Q4 | 1.9 Million USD | -87.54% |
| 2007 Q4 | 35.07 Million USD | -27.24% |
| 2007 Q2 | 46.18 Million USD | -3.16% |
| 2007 FY | 47.69 Million USD | 35.71% |
| 2007 Q1 | 47.69 Million USD | -1.35% |
| 2007 Q3 | 48.21 Million USD | 4.38% |
| 2006 Q4 | 48.34 Million USD | 25.52% |
| 2006 Q3 | 38.51 Million USD | 9.89% |
| 2006 Q2 | 35.05 Million USD | -0.27% |
| 2006 Q1 | 35.14 Million USD | 37.78% |
| 2006 FY | 35.14 Million USD | 198.51% |
| 2005 FY | -35.67 Million USD | 25.97% |
| 2005 Q4 | 25.5 Million USD | 319.14% |
| 2005 Q3 | 6.08 Million USD | 125.69% |
| 2005 Q2 | -23.68 Million USD | 33.6% |
| 2005 Q1 | -35.67 Million USD | 31.69% |
| 2004 Q1 | -48.19 Million USD | -1.63% |
| 2004 FY | -48.19 Million USD | -37.95% |
| 2004 Q4 | -52.22 Million USD | -1.63% |
| 2004 Q3 | -51.38 Million USD | 1.84% |
| 2004 Q2 | -52.34 Million USD | -8.63% |
| 2003 FY | -34.93 Million USD | -11.62% |
| 2003 Q3 | -44.27 Million USD | -29.12% |
| 2003 Q2 | -34.28 Million USD | 1.85% |
| 2003 Q1 | -34.93 Million USD | -8.29% |
| 2003 Q4 | -47.42 Million USD | -7.11% |
| 2002 Q3 | -31.25 Million USD | -33.26% |
| 2002 Q2 | -23.45 Million USD | 25.06% |
| 2002 Q1 | -31.29 Million USD | 15.19% |
| 2002 FY | -31.29 Million USD | 43.04% |
| 2002 Q4 | -32.25 Million USD | -3.2% |
| 2001 Q3 | -41.16 Million USD | 9.45% |
| 2001 Q2 | -45.45 Million USD | 19.59% |
| 2001 Q1 | -56.53 Million USD | -303.25% |
| 2001 FY | -54.94 Million USD | -282.48% |
| 2001 Q4 | -36.9 Million USD | 10.35% |
| 2000 Q2 | -14.36 Million USD | -286.73% |
| 2000 FY | -14.36 Million USD | -797.85% |
| 2000 Q3 | -14.4 Million USD | -0.25% |
| 2000 Q4 | -14.01 Million USD | 2.65% |
| 2000 Q1 | -3.71 Million USD | -118.51% |
| 1999 Q1 | -100 Thousand USD | 50.0% |
| 1999 Q4 | -1.7 Million USD | -70.0% |
| 1999 Q3 | -1 Million USD | 37.5% |
| 1999 FY | -1.6 Million USD | 5.88% |
| 1999 Q2 | -1.6 Million USD | -1500.0% |
| 1998 Q1 | -300 Thousand USD | 98.34% |
| 1998 Q3 | -1.8 Million USD | -5.88% |
| 1998 FY | -1.7 Million USD | -112.5% |
| 1998 Q4 | -200 Thousand USD | 88.89% |
| 1998 Q2 | -1.7 Million USD | -466.67% |
| 1997 Q4 | -18.1 Million USD | 48.58% |
| 1997 Q2 | -800 Thousand USD | 88.24% |
| 1997 Q1 | -6.8 Million USD | -100.0% |
| 1997 FY | -800 Thousand USD | 61.9% |
| 1997 Q3 | -35.2 Million USD | -4300.0% |
| 1996 Q4 | -3.4 Million USD | 67.92% |
| 1996 Q2 | -2.1 Million USD | 51.16% |
| 1996 Q1 | -4.3 Million USD | 34.85% |
| 1996 FY | -2.1 Million USD | 76.14% |
| 1996 Q3 | -10.6 Million USD | -404.76% |
| 1995 Q3 | -5.3 Million USD | 39.77% |
| 1995 FY | -8.8 Million USD | -100.0% |
| 1995 Q1 | -5.6 Million USD | -14.29% |
| 1995 Q2 | -8.8 Million USD | -57.14% |
| 1995 Q4 | -6.6 Million USD | -24.53% |
| 1994 Q2 | -4.4 Million USD | 60.71% |
| 1994 Q1 | -11.2 Million USD | -13.13% |
| 1994 Q3 | -6.9 Million USD | -56.82% |
| 1994 FY | -4.4 Million USD | 45.68% |
| 1994 Q4 | -4.9 Million USD | 28.99% |
| 1993 Q3 | -15.3 Million USD | -88.89% |
| 1993 Q4 | -9.9 Million USD | 35.29% |
| 1993 Q1 | -25.6 Million USD | 0.0% |
| 1993 Q2 | -8.1 Million USD | 68.36% |
| 1993 FY | -8.1 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 27.08 Million USD | -130.899% |
| BrainsWay Ltd. | -10.32 Million USD | 705.93% |
| Cerus Corporation | 84.35 Million USD | 25.868% |
| Envoy Medical, Inc. | -3.81 Million USD | 1739.539% |
| electroCore, Inc. | -9.95 Million USD | 728.147% |
| Helius Medical Technologies, Inc. | -5.12 Million USD | 1320.137% |
| IceCure Medical Ltd | -9.93 Million USD | 729.475% |
| Inogen, Inc. | -103.56 Million USD | 160.377% |
| OrthoPediatrics Corp. | -9.26 Million USD | 774.781% |
| Lucid Diagnostics Inc. | -3.64 Million USD | 1817.44% |
| Monogram Orthopaedics, Inc. | -13.09 Million USD | 577.451% |
| MaxCyte, Inc. | -27.76 Million USD | 325.235% |
| NeuroOne Medical Technologies Corporation | -5.13 Million USD | 1317.027% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | 10960.643% |
| Orthofix Medical Inc. | 96.44 Million USD | 35.161% |
| PAVmed Inc | 29.08 Million USD | -114.99% |
| Rapid Micro Biosystems, Inc. | -16.93 Million USD | 469.16% |
| RxSight, Inc. | -6.68 Million USD | 1036.108% |
| Sight Sciences, Inc. | -102.71 Million USD | 160.879% |
| SI-BONE, Inc. | 5.72 Million USD | -993.026% |
| TELA Bio, Inc. | -3.94 Million USD | 1683.489% |
| Treace Medical Concepts, Inc. | 57.32 Million USD | -9.091% |
| Vivos Therapeutics, Inc. | 352 Thousand USD | -17664.773% |
| Acutus Medical, Inc. | 12.27 Million USD | -409.26% |
| Talis Biomedical Corporation | -57.06 Million USD | 209.582% |
| Spectral AI, Inc. | -3.5 Million USD | 1886.118% |
| Nano-X Imaging Ltd. | -48.02 Million USD | 230.202% |
| CVRx, Inc. | -59.95 Million USD | 204.296% |
| DIH Holding US, Inc. Warrants | 1.98 Million USD | -3051.584% |
| PetVivo Holdings, Inc. | 1.27 Million USD | -4794.348% |
| Bioventus Inc. | 372.51 Million USD | 83.213% |
| Venus Concept Inc. | 74.3 Million USD | 15.84% |
| TriSalus Life Sciences, Inc. | -10.18 Million USD | 714.143% |
| 908 Devices Inc. | -115.09 Million USD | 154.33% |
| Alphatec Holdings, Inc. | 320.7 Million USD | 80.502% |
| Nemaura Medical Inc. | 9.92 Million USD | -530.044% |
| NeuroPace, Inc. | 54.33 Million USD | -15.082% |
| LENSAR, Inc. | -18.31 Million USD | 441.481% |
| Apyx Medical Corporation | -5.15 Million USD | 1313.978% |
| Cutera, Inc. | 288.3 Million USD | 78.31% |
| STRATA Skin Sciences, Inc. | 7.51 Million USD | -732.096% |
| BioSig Technologies, Inc. | 262 Thousand USD | -23767.176% |
| Anika Therapeutics, Inc. | -43.83 Million USD | 242.669% |
| ClearPoint Neuro, Inc. | -9.19 Million USD | 779.77% |
| Integra LifeSciences Holdings Corporation | 1.4 Billion USD | 95.55% |
| Axonics, Inc. | -77.19 Million USD | 181.006% |
| Outset Medical, Inc. | 67.67 Million USD | 7.605% |
| IRIDEX Corporation | -4.28 Million USD | 1558.302% |
| PROCEPT BioRobotics Corporation | -178.01 Million USD | 135.127% |
| IRadimed Corporation | -47.71 Million USD | 231.042% |
| Tivic Health Systems, Inc. | -3.02 Million USD | 2166.49% |
| INVO Bioscience, Inc. | 8.45 Million USD | -639.924% |
| Telesis Bio, Inc. | 32.63 Million USD | -91.61% |
| Viemed Healthcare, Inc. | -2.5 Million USD | 2599.149% |
| Varex Imaging Corporation | 316.9 Million USD | 80.268% |
| Quipt Home Medical Corp. | 81.73 Million USD | 23.494% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | 2347.735% |
| Pulmonx Corporation | -42.36 Million USD | 247.62% |
| Dynatronics Corporation | 6.2 Million USD | -907.925% |
| Modular Medical, Inc. | -8.04 Million USD | 877.568% |
| ReShape Lifesciences Inc. | -4.29 Million USD | 1555.248% |
| Semler Scientific, Inc. | -57.13 Million USD | 209.456% |
| InMode Ltd. | -135.39 Million USD | 146.185% |
| Bruker Corporation | 891.3 Million USD | 92.984% |
| Cytosorbents Corporation | 4.18 Million USD | -1395.26% |
| DexCom, Inc. | 2.02 Billion USD | 96.916% |
| Align Technology, Inc. | -840.47 Million USD | 107.44% |
| Viveve Medical, Inc. | -13.81 Million USD | 552.704% |
| ZimVie Inc. | 450.41 Million USD | 86.117% |
| Movano Inc. | -5.86 Million USD | 1166.008% |
| Cytek Biosciences, Inc. | -134.45 Million USD | 146.507% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | 10960.643% |
| DIH Holdings US, Inc. Class A Common Stock | 1.98 Million USD | -3051.584% |
| Tandem Diabetes Care, Inc. | 356.79 Million USD | 82.474% |
| Profound Medical Corp. | -18.17 Million USD | 443.988% |
| Insulet Corporation | 798.1 Million USD | 92.165% |
| enVVeno Medical Corporation | -2.21 Million USD | 2919.297% |
| Surmodics, Inc. | -12.01 Million USD | 620.493% |
| iCAD, Inc. | -21.2 Million USD | 394.837% |
| Nuwellis, Inc. | -2.81 Million USD | 2318.233% |
| Biotricity, Inc. | 23.09 Million USD | -170.787% |
| iRhythm Technologies, Inc. | 93.65 Million USD | 33.229% |
| Aethlon Medical, Inc. | -4.5 Million USD | 1489.087% |
| InspireMD, Inc. | -8.04 Million USD | 877.278% |
| PAVmed Inc. | 29.08 Million USD | -114.99% |
| BIOLASE, Inc. | 11.34 Million USD | -451.234% |
| Beyond Air, Inc. | 6.22 Million USD | -903.885% |
| FONAR Corporation | -14.66 Million USD | 526.394% |
| AxoGen, Inc. | 32.26 Million USD | -93.802% |
| Vivani Medical, Inc. | 42 Thousand USD | -148785.714% |
| Tactile Systems Technology, Inc. | -10.65 Million USD | 686.714% |
| Inari Medical, Inc. | -7.16 Million USD | 973.23% |
| UFP Technologies, Inc. | 40.77 Million USD | -53.362% |
| QT Imaging Holdings, Inc. | 3.06 Million USD | -1937.786% |
| Heart Test Laboratories, Inc. | -4.77 Million USD | 1410.583% |
| Tenon Medical, Inc. | -1.25 Million USD | 5082.629% |
| Autonomix Medical, Inc. Common Stock | -7.6 Million USD | 922.14% |
| Co-Diagnostics, Inc. | -11.92 Million USD | 624.32% |
| AdaptHealth Corp. | 2.21 Billion USD | 97.18% |
| Sintx Technologies, Inc. | 905 Thousand USD | -6809.613% |
| NanoVibronix, Inc. | -3.27 Million USD | 2007.627% |
| Quanterix Corporation | -132.95 Million USD | 147.031% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | 2347.735% |
| Sensus Healthcare, Inc. | -22.36 Million USD | 379.598% |
| Pacific Biosciences of California, Inc. | 753.71 Million USD | 91.704% |
| TransMedics Group, Inc. | 121.13 Million USD | 48.378% |
| ReWalk Robotics Ltd. | -26.18 Million USD | 338.854% |
| NeuroMetrix, Inc. | -1.49 Million USD | 4293.767% |
| Hyperfine, Inc. | -75.61 Million USD | 182.694% |
| Establishment Labs Holdings Inc. | 152.18 Million USD | 58.912% |
| Biomerica, Inc. | -3.38 Million USD | 1947.326% |
| Bone Biologics Corporation | -3.02 Million USD | 2166.102% |
| AVITA Medical, Inc. | -26.23 Million USD | 338.384% |
| Bluejay Diagnostics, Inc. | -1.83 Million USD | 3501.416% |
| Silk Road Medical, Inc | 64.42 Million USD | 2.935% |